Clinical Benefit of Ablating Localized Sources for Human Atrial Fibrillation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Benefit of Ablating Localized Sources for Human Atrial Fibrillation: The Indiana University FIRM Registry
J Am Coll Cardiol 2017 Mar 14;69(10)1247-1256, JM Miller, V Kalra, MK Das, R Jain, JB Garlie, JA Brewster, G DandamudiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.